Medical Large Language Model-Assisted Diagnosis and Treatment in Primary Care Chronic Disease Management
NCT07740044
Arrhythmias, Cardiac, Arterial Occlusive Diseases
Taizhou, Jiangsu, China
View Trial DetailsNCT Number: NCT07440472
This multicenter prospective observational feasibility study evaluates the implementation of the RAPHAEL model, a remote monitoring palliative care approach for patients with heart failure. The study aims to assess the feasibility, acceptability, usability, and implementation outcomes of integrating structured remote symptom monitoring and palliative care needs assessment into routine outpatient heart failure care.
Adult patients with heart failure and worsening symptoms and/or potential palliative care needs will complete a structured digital questionnaire during a 4-week follow-up period. Healthcare professionals will review reported needs and conduct follow-up contact according to usual clinical practice. No experimental drugs or devices are administered, and clinical management remains at the discretion of the treating team.
Primary outcomes focus on feasibility and implementation metrics, including participation rates, acceptability, usability, perceived burden, resource requirements, fidelity to the intervention model, training adoption, applicability, adaptation, and demand.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Universitaetsklinikum Aachen, Aachen, Germany
The RAPHAEL study (Work Package 4) is a multicenter, prospective observational feasibility study conducted across participating European clinical sites. The objective is to evaluate the implementation of a structured remote monitoring palliative care model integrated into routine outpatient heart failure care.
Patients with a confirmed diagnosis of heart failure who present with worsening symptoms and/or indicators of palliative care needs will be invited to participate. Participants will complete a structured digital questionnaire designed to identify symptom burden, psychosocial concerns, and potential unmet palliative care needs. The questionnaire is administered once during a 4-week observation period.
Healthcare professionals trained in the RAPHAEL model will review questionnaire responses and may initiate follow-up contact or clinical actions according to standard clinical judgment and existing care pathways. The study does not mandate changes to pharmacological treatment, and all medical decisions remain under routine clinical practice.
The primary objective is to assess feasibility and implementation outcomes, including recruitment capability, participation rates, acceptability, usability, perceived burden for patients and professionals, fidelity to the intervention components, required resources, adaptation processes, and demand. Secondary objectives include descriptive assessment of symptom burden and identified palliative care needs.
The study is classified as an observational prospective study according to ethics committee approval. No randomization, experimental interventions, or investigational medicinal products are involved.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients
'Would I be surprised if this patient were to die within one year?'
Primary Caregiver:
Healthcare professionals: Two professionals identified by the consortium in each site, willing to be trained in the intervention to perform the feasibility study.
Exclusion criteria
Primary caregivers:
Health care professionals: a) Inability to read and write fluently in the language(s) required for the study site and for using the digital questionnaire.
Time frame: 4 weeks
Participation will be measured as the proportion of eligible patients with heart failure who provide informed consent and enroll in the RAPHAEL intervention during the 4-week observation period. Unit of Measure: Percentage (%) Calculated as follows:
Numerator: Number of eligible patients who provide written informed consent and are enrolled.
Denominator: Total number of eligible patients approached for participation by healthcare professionals.
The prespecified feasibility criterion for success is a participation rate greater than 60%.
Time frame: 4 weeks
Patient-reported acceptability of the digital questionnaire and follow-up process assessed using structured evaluation questions at the end of the 4-week observation period. It will be evaluated using a Likert scale (0 - Completely inappropriate, 1 - Rather inappropriate, 2 - Rather appropriate, 3 - Completely appropriate). A 4-point scale was selected to minimize respondent burden and to facilitate cross-country comparability, while still capturing meaningful differences in perception. Criterion: ≥ 75% of patients score ≥ 2.
Time frame: 4 weeks
Participant-reported usability of the structured digital questionnaire, including ease of use and clarity of questions, assessed at the end of the observation period. It will be evaluated using a dichotomous answer (yes/no). Criterion: ≥ 75% of patients consider the intervention to be easy to use.
Time frame: 4 weeks
Patient-reported perceived burden associated with completing the questionnaire and participating in the study procedures. This will be measured using a Likert scale (0 - no burden, 1 - Light burden, 2 - Moderate burden, 3 - Heavy burden). Criterion: ≥ 75% of participants rate the burden as ≤ 1.
Time frame: 4 weeks
Proportion of cases in which healthcare professionals reviewed questionnaire responses and documented follow-up actions according to the study framework. Criterion: ≥ 80% of the patients complete the 4 steps of the RAPHAEL intervention during their enrollment.
Time frame: 4 weeks
Assessment of healthcare professional engagement with and adoption of the RAPHAEL model during the study period. Criterion: all participating healthcare professionals complete the final assignment of the online training.
Contact information is provided by the study sponsor or research team.
Universitat Internacional de Catalunya
Other
Feasibility of Implementing a Remote Monitoring Palliative Care Model for Patients With Heart Failure.
Acronym: RAPHAEL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07740044
Arrhythmias, Cardiac, Arterial Occlusive Diseases
Taizhou, Jiangsu, China
View Trial DetailsNCT07737964
Cardiovascular Diseases, Heart Diseases
Amiens, France
View Trial DetailsNCT07731048
Cardiovascular Diseases, Heart Diseases
Porto Alegre, Rio Grande do Sul, Brazil
View Trial DetailsNCT05996328
Cardiovascular Diseases, Heart Diseases
Ann Arbor, Michigan, United States
View Trial Details